GLP-1 drugs found to lower cancer risk in diabetes patients

FHS
July 9, 2024
2:22 am

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

Roche strikes neuro-focused partnership with RNA exon editing startup, worth as much as $1.8B

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 19, 2024

Wonky Period After COVID Vaccine May Only Happen During One Phase

Women vaccinated against COVID-19 during the follicular phase of their period had their next cycle last 1 day longer than normal, according to a retrospective

March 5, 2024

Protecting your drug products: Strategies for preventing metal contamination in powders – Pharmaceutical Technology

Any metal contamination in pharmaceutical products is a huge problem. First and foremost, there are possible safety implications for patients that may ingest contaminates. For

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.